Use of recombinant human bone morphogenetic protein-2 to enhance posterior cervical spine fusion at 2 years of age: Technical note

Pediatric Neurosurgery

Volumn 44, Issue 5, 2008, Pages 393-396

  Oluigbo, Chima O ^a   Solanki, Guirish A ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Bone morphogenetic protein; Cervical spine fusion; Growth factor; Pediatric neurosurgery; Pediatric spine

Indexed keywords

COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANKYLOSIS; ARTICLE; BONE GRAFT; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DECUBITUS; FEMALE; FOLLOW UP; FRACTURE FIXATION; HEART ARRHYTHMIA; HUMAN; IMMOBILIZATION; ORTHOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUADRIPLEGIA; RADIOLOGY; SPINAL CORD INJURY; SPINE FUSION; SPINE INSTABILITY; SURGICAL TECHNIQUE; TRAFFIC ACCIDENT;

AGE FACTORS; BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; CHILD, PRESCHOOL; FEMALE; HUMANS; RECOMBINANT PROTEINS; SPINAL FRACTURES; SPINAL FUSION; TRANSFORMING GROWTH FACTOR BETA;

EID: 49249110231     PISSN: 10162291     EISSN: None     Source Type: Journal    
DOI: 10.1159/000149907     Document Type: Article

References (20)

1. Boden SD, Zdeblick TA, Sandhu HS, Heim SE: The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-381.
2. Burkus JK, Gornet MF, Dickman CA, Zdeblick TA: Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15:337-349.
3. Burkus JK, Transfeldt EE, Kitchel SH, Watkins RG, Balderston RA: Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human morphogenetic protein-2. Spine 2002;27:2396-2408.
4. Boden SD, Kang J, Sandhu H, Heller JG: Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumbar spine fusion in humans: a prospective, randomized clinical pilot trial. 2002 Volvo Award in Clinical Studies. Spine 2002;27:2662-2673.
5. Baskin DS, Ryan P, Sonntag V, Westmark R, Widmayer MA: A prospective, randomized, controlled cervical fusion study using recombinant human bone morphogenetic protein-2 with the CORNERSTONE-SR allograft ring and the ATLANTIS anterior cervical plate. Spine 2003;28:1219-1225.
6. Boakye M, Mummaneni PV, Garrett M, Rodts G, Haid R: Anterior cervical discectomy and fusion involving a polyetheretherketone spacer and bone morphogenetic protein. J Neurosurg 2005;2:521-525.
7. Shields LBE, Raque GH, Glassman SD, Campbell M, Vitaz T, Harpring J, Shields CB: Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006;31:542-547.
8. Urist MR: Bone formation by autoinduction. Science 1965;150:893-899.
9. Urist MR, Mikulski A, Lietze A: Solubilized and insolubilized bone morphogenetic protein. Proc Natl Acad Sci USA 1979;76:1828-1832.
10. Wang EA, Rosen V, Cordes P, Hewick RM, Kriz MJ, Luxenberg DP, Sibley BS, Wozney JM: Purification and characterization of other distinct bone-inducing factors. Proc Natl Acad Sci USA 1988;85:9484-9488.
11. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hezwick RM, Wang EA: Novel regulators of bone formation: molecular clones and activities. Science 1988;242:1528-1534.
12. Celeste AJ, Iannazzi JA, Taylor RC, Hewick RM, Rosen V, Wang EA, Wozney JM: Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. Proc Natl Acad Sci USA 1990;87:9843-9847.
13. Schimandle JH, Boden SD, Hutton WC: Experimental spinal fusion with recombinant human bone morphogenetic protein-2. Spine 1995;20:1326-1337.
14. Sandhu HS, Kanim LEA, Kabo JM, Toth JM, Zeegen EN, Liu D, Delamarter RB, Dawson EG: Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion. Spine 1996;21:2115-2122.
15. Sandhu HS, Kanim LEA, Toth JM, Kabo JM, Liu D, Delamarter RB, Dawson EG: Experimental spinal fusion with recombinant bone morphogenetic protein-2 without decortication of osseous elements. Spine 1997;22:1171-1180.
16. Fischgrund JS, James SB, Chabot MC, Hankin R, Herkowitz HN, Wozney JM, Shirk hoda A: Augmentation of autograft using rhBMP-2 and different carrier media in the canine spinal fusion model. J Spinal Disord 1997;10:467-472.
17. Martin GJ, Boden SD, Morone MA, Moskovitz PA: Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a non-human primate: important lessons learned regarding dose, carrier and safety. J Spinal Disord 1999;12:179-186.
18. Sidhu KS, Prochnow TD, Schmitt P, Fischgrund J, Weisbrode S, Herkowitz HN: Anterior cervical interbody fusion with rhBMP-2 and tantalum in a goat model. Spine J 2001;1:331-340.
19. Zhang H, Sucato DJ, Welch RD: Recombinant human bone morphogenetic protein-2-enhanced anterior spine fusion without bone encroachment into the spinal canal: a histomorphometric study in a thoracoscopically instrumented porcine model. Spine 2005;30:512-518.
20. Poynton AR, Lane JM: Safety profile for the clinical use of bone morphogenetic proteins in the spine. Spine 2002;27(suppl 1):S40-S48.